Literature DB >> 21835167

Time-imposed daily restricted feeding induces rhythmic expression of Fgf21 in white adipose tissue of mice.

Katsutaka Oishi1, Morichika Konishi, Yusuke Murata, Nobuyuki Itoh.   

Abstract

Fibroblast growth factor 21 (FGF21) is a key metabolic regulator that is induced by fasting and starvation, and its expression is thought to be regulated by the circadian clock in the liver. To evaluate the functional role of FGF21 in the circadian regulation of physiology and behavior, we examined the temporal expression profiles of Fgf21 and circadian clock genes in addition to behavioral activity rhythms under adlibitum feeding (ALF) and time-imposed restricted feeding (RF) in mice. Four hours of daily restricted feeding during the daytime induced over an 80-fold increase in feeding-dependent rhythmic Fgf21 mRNA expression in epididymal white adipose tissue (eWAT), although the expression levels were continuously increased 10-fold in the liver of wild-type (WT) mice. Refeeding subsequent to transient fasting revealed that refeeding but not fasting remarkably induces Fgf21 expression in eWAT, although fasting-induced hepatic Fgf21 expression is completely reversed by refeeding. The free-running period of locomotor activity rhythm under ALF and the food anticipatory activity (FAA) under RF remained intact in Fgf21 knockout (KO) mice, suggesting that FGF21 is dispensable for both the central clock in the suprachiasmatic nucleus (SCN) and the food-entrainable oscillator that governs the FAA. Temporal expression profiles of circadian genes such as mPer2 and BMAL1 were essentially identical in both tissues between WT and Fgf21 KO mice under RF. The physiological role of the refeeding-induced adipose Fgf21 expression remains to be elucidated.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835167     DOI: 10.1016/j.bbrc.2011.07.125

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine.

Authors:  Matthew J Potthoff; Steven A Kliewer; David J Mangelsdorf
Journal:  Genes Dev       Date:  2012-02-02       Impact factor: 11.361

Review 2.  Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

Review 3.  Bone as an endocrine organ.

Authors:  Anyonya R Guntur; Clifford J Rosen
Journal:  Endocr Pract       Date:  2012 Sep-Oct       Impact factor: 3.443

4.  Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).

Authors:  E B Nygaard; C L Møller; P Kievit; K L Grove; B Andersen
Journal:  Int J Obes (Lond)       Date:  2013-05-21       Impact factor: 5.095

5.  Fibroblast growth factor 21: a novel metabolic regulator.

Authors:  Ji A Seo; Nan Hee Kim
Journal:  Diabetes Metab J       Date:  2012-02-17       Impact factor: 5.376

6.  Cell biology. FGF21 takes a fat bite.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Science       Date:  2012-05-11       Impact factor: 47.728

Review 7.  Beta-klotho in type 2 diabetes mellitus: From pathophysiology to therapeutic strategies.

Authors:  Shuang Hua; Qianying Liu; Jufei Li; Mengqi Fan; Kaixuan Yan; Dewei Ye
Journal:  Rev Endocr Metab Disord       Date:  2021-06-13       Impact factor: 6.514

8.  Continuous exposure to a novel stressor based on water aversion induces abnormal circadian locomotor rhythms and sleep-wake cycles in mice.

Authors:  Koyomi Miyazaki; Nanako Itoh; Sumika Ohyama; Koji Kadota; Katsutaka Oishi
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

9.  Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress.

Authors:  Chaofeng Yang; Weiqin Lu; Tao Lin; Pan You; Min Ye; Yanqing Huang; Xianhan Jiang; Cong Wang; Fen Wang; Mong-Hong Lee; Sai-Ching J Yeung; Randy L Johnson; Chongjuan Wei; Robert Y Tsai; Marsha L Frazier; Wallace L McKeehan; Yongde Luo
Journal:  BMC Gastroenterol       Date:  2013-04-17       Impact factor: 3.067

10.  βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism.

Authors:  Xunshan Ding; Jamie Boney-Montoya; Bryn M Owen; Angie L Bookout; Katie Colbert Coate; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2012-09-05       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.